ARGS

Argos Therapeutics, Inc.
ARGS

Overview Fund Activity
Delisted

ARGS was delisted on the 24th of April, 2018.

Back to rankings

25 hedge funds and large institutions have $9.3M invested in Argos Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 5 closing their positions.

Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
FG
1
Formula Growth
Quebec, Canada
$162K
2
PSI
2
Pinnacle Summer Investments
Virginia
$354K
3
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
$467K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$82K
5
SIM
5
Spark Investment Management
New York
$79K

Top Sellers

1
AIC
1
AWM Investment Company
New York
$0
2
CS
2
Credit Suisse
Switzerland
$0
3
WA
3
Wasatch Advisors
Utah
$5.26M
4
TRCT
4
Tower Research Capital (TRC)
New York
$0
5
UBS Group
5
UBS Group
Switzerland
$0
Name Market Value Shares Shares
Change 		Shares
Change %
CS
26
Credit Suisse
Switzerland
– – -31,955 Closed
TRCT
27
Tower Research Capital (TRC)
New York
– – -4,795 Closed
UBS Group
28
UBS Group
Switzerland
– – -2,744 Closed
Citigroup
29
Citigroup
New York
– – -154 Closed
Deutsche Bank
30
Deutsche Bank
Germany
$0 236 +236 New
1
2